cell activation leads to the production of autoantibodies and polyclonal hyper-gammaglobulinaemia characteristic of SS, and the B cell activation may account for the increased propensity of these patients to developing lymphomas (7) . BAFF is a member of the TNF superfamily, and is involved in B cell maturation and survival. It was found at increased levels in serum, and salivary tissues of the patients with SS, and is expressed by T cells (8) . Moreover, BAFF transgenic mice display a phenotype similar to SS or SLE (9) . These data imply an important role for T and B cell interaction in the pathogenesis of salivary gland autoimmunity.
ROLE OF APOPTOSIS
Apoptosis plays an important role in maintaining T cell repertoire and deletion of autoreactive T cells (10, 11) , and is regulated by a number of gene products that promote cell death or extend cell survival (12, 13) . Fas ligand (FasL) mediates cell death by cross-linking Fas receptor in apoptosis-sensitive Fas + cells (14, 15) . It is now evident that the interaction of Fas with FasL regulates a large number of pathophysiological processes of apoptosis including autoimmune diseases (16) (17) (18) (19) . Recent studies have confirmed the observation that apoptotic cells in various cell types implicated as the sourse of autoantigen when stimulated with different proapoptotic stimuli (20) (21) (22) . Much evidence shows that β-cell apoptosis is a fundamental process involved in the pathogenesis of type 1 diabetes (23, 24) . In addition to apoptosis being the main mechanism by which β cells are destroyed, β-cell apoptosis has been implicated in the initiation of type 1 diabetes mellitus. These studies support that exaggerated β-cell damage can induce activation of β-cell-specific T cells. Therefore, the apoptotic cells may be a critical determinant contributing to the initiation of autoimmunity by having the capacity to instruct antigenpresenting cells (APCs) to modulate immune responses so that the outcome is T cell activation. Our previous reports identified a 120 kDa α-fodrin as an important autoantigen in murine and human SS (25, 26) . It has demonstrated definitively the intracellular pathway of Ro, La and α-fodrin autoantigens as a result of apoptosis, suggesting a possible mechanism by which antigens may be exposed at the cell surface to APCs such as macrophages or dendritic cells (DC). Although cleavage of certain autoantigens during apoptosis may reveal immunocryptic epitopes that could potentially induce autoimmune responses in systemic autoimmune diseases (19, 27) , accumulated evidences suggest an important role of apoptosis in the disease pathogenesis of SS (28, 29) . We found that a significant increase of TUNEL + -apoptotic epithelial duct cells in the salivary glands was detected in NFS/sld SS model, compared with those in control mice at all ages (30) . Moreover, we confirmed that tissue-infiltrating CD4 + T cells are responsible for tissue destruction as judged by in vitro 51 Cr release cytotoxic assay against MSG cells (30) . Although it has been reported that Fas-induced apoptosis seems to be the major killing pathway of the CD4 + cytotoxic T cells (31) , our data suggest that one mechanism by which activated CD4 + T cells induce cytotoxicity towards salivary gland cells in murine SS model is Fas-based (30) . Our recent immunofluorescence analysis from SS patients demonstrated that a cleavage product of α-fodrin was present in epithelial duct cells of the labial salivary gland biopsies from SS patients, but not in control glands (26) . These data suggest that increased activity of caspase cascade is involved in the progression of α-fodrin proteolysis during the initial stages on the development of primary SS.
SALIVARY GLAND AUTOIMMUNITY DE-VELOPS IN RbAp48-TG MICE
We have generated RbAp48-Tg mice where the RbAp48 gene is expressed in the salivary and lacrimal glands using the gland-specific promoter (32, 33) . When the histopathology of all organs from those mice were analyzed, we found that autoimmune exocrinopathy resembling SS developed in almost all RbAp48-Tg mice at 24-wks-old or more, but not in the wild-type (WT) mice. Lymphocyte infiltration in salivary glands of RbAp48-Tg mice becomes more frequent at around 30-to 50-wks of age, and a significantly higher incidence of inflammatory lesions was found in female Tg mice at all ages. Many infiltrating lymphocytes were observed in periductal areas with varying degrees, and shown in focal appearance. A majority of infiltrating cells in salivary and lacrimal glands was Thy1. 
SALIVARY GLAND EPITHELIAL CELLS AS ANTIGEN-PRESENTING CELLS
It has been well known that nonlymphoid cells that express MHC class II molecules provoke autoimmune responses (35, 36) (Fig. 1) . MSG cells were enriched by enzymatic treatment, several antibodies against immune cells and epithelial cells, and magnetic beads. On the other hand, although the expressions of MHC Class II and CD86 on the splenocytes and CD11c + DCs were higher than those on both MSG cells, the expressions of CD80 and ICAM-1 on the professional APCs were similar or lower than those on the MSG + T cells of cLNs from RbAp48-Tg mice were more proliferative to the MSG cells from RbAp48-Tg mice relative to those from WT mice (33) .
CRUCIAL ROLE OF EPITHELIAL IFN-PRODUCTION
The expression of MHC class II molecules is generally regulated at the transcriptional levels including the transcription factor interferon regulatory factor (IRF)-1 (38, 39) and the class II transactivator (CIITA), the master regulator for MHC class II gene expression (40, 41) . It has been shown that IRF-1 is a primary responsible gene of the IFN-γ response (42) . In in vitro studies using human salivary gland (HSG) cells (43), IFN-γ-induced mRNAs of IRF-1 and CIITA were significantly enhanced by the treatment of Tamoxifen (Tam), which is an antagonist of estrogen and can induce RbAp48 (44), or transfection of pCMV-RbAp48 plasmid in the dose-dependent manner, not in MCF-7 cells (human mammary gland cell line). In addition, we analyzed the IRF-1 promoter activity using RbAp48-transfected HSG cells with and without IFN-γ by luciferase assay. We observed significantly enhanced IRF-1 promoter activity in RbAp48-transfected HSG cells with IFN-γ, not in MCF-7 cells. To our surprise, in RbAp48-Tg mice, a prominent expression of IFN-γ was detected in salivary epithelial cells besides sporadically positive infiltrating cells of RbAp48-Tg mice, not WT mice. These findings were observed mainly in the MHC class II + ductal epithelium adjacent to lymphoid infiltrates. Epithelial IFN-γ expression in the exocrine glands of RbAp48-Tg mice was up-regulated during the course of autoimmune exocrinopathy (33) . Induction of IFN-γ expression may occur through many different types of stimulation, including cross-linking of cell-surface receptors and stimulation with cytokines, including IL-2, IL-12, and IL-18 (44) (34) . It has been demonstrated that IFN-γ synthesis is predominantly induced by stimulation with IL-18 (45) . Consistent with a previous report (46) , IL-18 expression was observed in salivary epithelial cells in RbAp48-Tg mice, not in WT mice. Confocal analysis revealed that differential expression of IL-18 and IFN-γ was clearly observed, i.e. IL-18 mainly in the acinar cells and IFN-γ in the duct cells, within salivary epithelial cells from RbAp48-Tg mice, not from WT mice (Fig. 2) . Epithelial IFN-γ and IL-18 productions were confirmed by flow cytometry using MSG cells without immune cells from RbAp48-Tg, not from WT mice, while there was no difference in both IFN-γ and IL-18 expressions of cLN cells between WT and RbAp48-Tg mice. Although the production of IL-18 in salivary gland cells has been detected in a previous report (46) , there has been no proof for IFN-γ production of salivary gland cells in any report. Therefore, to confirm IFN-γ production of salivary glands, detection of IFN-γ using tissue homogenates was performed. High concentration of IFN-γ was detected in the tissue homogenates of salivary glands from RbAp48-Tg mice by ELISA. Furthermore, the detection of IFN-γ mRNA of MSG cells was performed by in situ hybridization using the RNA probe of mouse IFN-γ gene. More intensive signal for IFN-γ mRNA in duct cells of salivary glands from RbAp48-Tg mice was observed compared with that from WT mice. In vitro studies using HSG cells demonstrated that the expressions of IL-18, IFN-γ and MHC class II (HLA -DR) were observed when treated with Tam or transfected with pCMV-RbAp48, while they were inhibited when treated with 17β-estradiol (E2), caspase 1 inhibitor (Ac-YVAD-CHO) (Ci), and siRNA of RbAp48 (si). Confocal analysis confirmed the expressions of IL-18, and IFN-γ in HSG cells treated with Tam or transfected with pCMV-RbAp48. It is important to note that IL-18 is secreted earlier (by 6 hours) than IFN-γ production and HLA-DR expression (by 12 hours) in Tamstimulated and RbAp48-transfected HSG cells.
CONCLUDING REMARKS
We demonstrated that autoimmune exocrinopathy resembling SS developed in almost all RbAp48-Tg mice, and that a high titer of serum autoantibodies against SS-A (Ro), SS-B (La) and 120 kDa α-fodrin was detected in these Tg mice. We found frequently MHC class II molecule expression on the exocrine gland cells with autoimmune lesions in RbAp48-Tg mice. Although it has been undetermined whether MHC class II-expressing epithelial cells can function as antigen-presenting cells, our data strongly suggest that the epithelial cells may function as antigen-presenting cells during development of autoimmunity. In RbAp48-Tg mice, a prominent expression of epithelial IFN-γ was detected besides sporadically positive infiltrating cells. These findings were observed mainly in the MHC class II + ductal epithelium. Epithelial IFN-γ expression in the salivary glands was up-regulated during the course of autoimmune exocrinopathy. These data demonstrate a direct molecular mechanism by which estrogen deficiency induces tissue-specific overexpression of RbAp48, subsequently developing CD4 + T cell-mediated autoimmunity through epithelial IFN-γ production. Thus, reducing the RbAp48 overexpression is a possible effective therapy for gender-based autoimmunity in the salivary glands.
